GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP) (Q2KE66)

Analyse AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q2KE66
Type
protein
Length
536 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xFcE1Cc4701f91032c0E3B0766A064D09cFFc5BeC
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
UniProt
Q2KE66
Pockets
3 · best druggability 0.74

Structure

1 distinct chain · 32% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP)protein53632% helix, 25% strandQ2KE66

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17600.740.7966empty
2530.490.8617empty
31340.430.7627empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.